These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6438657)

  • 1. The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies.
    Carr DH
    Physiol Chem Phys Med NMR; 1984; 16(2):137-44. PubMed ID: 6438657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast agents in magnetic resonance imaging.
    Carr DH; Gadian DG
    Clin Radiol; 1985 Nov; 36(6):561-8. PubMed ID: 2998682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and gadolinium chelates as contrast agents in NMR imaging: preliminary studies.
    Carr DH; Brown J; Leung AW; Pennock JM
    J Comput Assist Tomogr; 1984 Jun; 8(3):385-9. PubMed ID: 6427304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal chelates as urographic contrast agents for magnetic resonance imaging. A comparative study.
    Marotti M; Schmiedl U; White D; Ramos E; Johnson T; Engelstad B
    Rofo; 1987 Jan; 146(1):89-93. PubMed ID: 3027795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B; Laniado M; Saini S
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of proton relaxation enhancers in magnetic resonance imaging.
    Carr DH
    Magn Reson Imaging; 1985; 3(1):17-25. PubMed ID: 3923290
    [No Abstract]   [Full Text] [Related]  

  • 7. [NMR tomography with gadolinium-DTPA of the trunk in pediatric oncology].
    Kahn T; Fürst G; Wessalowski R; Jürgens H; Göbel U; Kemperdick HF; Mödder U
    Rofo; 1989 May; 150(5):592-7. PubMed ID: 2541488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paramagnetic pharmaceuticals for magnetic resonance imaging.
    Wesbey GE; Engelstad BL; Brasch RC
    Physiol Chem Phys Med NMR; 1984; 16(2):145-55. PubMed ID: 6095341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paramagnetic contrast media for magnetic resonance imaging of the mediastinum and lungs.
    Carr DH
    J Thorac Imaging; 1985 Dec; 1(1):74-8. PubMed ID: 3939639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.
    Wesbey GE; Brasch RC; Goldberg HI; Engelstad BL; Moss AA
    Magn Reson Imaging; 1985; 3(1):57-64. PubMed ID: 3923293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fat-suppressed MR imaging sequences in the diagnosis of liver and pancreatic neoplasms at 1.5 tesla].
    Hagspiel KD; Neidl KF; Hauser M; Duewell S; Marincek B
    Rofo; 1994 Mar; 160(3):235-42. PubMed ID: 8136477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results].
    Hamm B; Römer T; Felix R; Wolf KJ
    Rofo; 1986 Dec; 145(6):684-91. PubMed ID: 3025957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic strategy in liver and pancreatic tumors: imaging diagnosis using MRT].
    Langkowski JH
    Rontgenblatter; 1989 Sep; 42(9):400-5. PubMed ID: 2552566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular contrast agents suitable for magnetic resonance imaging.
    Runge VM; Clanton JA; Herzer WA; Gibbs SJ; Price AC; Partain CL; James AE
    Radiology; 1984 Oct; 153(1):171-6. PubMed ID: 6433402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced MR imaging of the pancreas.
    Kettritz U; Semelka RC
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
    Rummeny EJ; Peters PE
    Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties and pharmacokinetics.
    Goldstein EJ; Burnett KR; Hansell JR; Casaia J; Dizon J; Farrar B; Gelblum D; Wolf GL
    Physiol Chem Phys Med NMR; 1984; 16(2):97-104. PubMed ID: 6095342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver I: Currently available gadolinium chelates.
    Mitchell DG
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):37-51. PubMed ID: 8673715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic spin-echo MRI of liver cancer using Gadolinium-DTPA: animal investigation.
    Saini S; Stark DD; Brady TJ; Wittenberg J; Ferrucci JT
    AJR Am J Roentgenol; 1986 Aug; 147(2):357-62. PubMed ID: 3487953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.